Merz Clarifies Status of Xeomin, Appoints William (Bill) Humphries CEO
Following a hearing in US District Court yesterday, Merz, Inc. is clarifying the availability of Xeomin and has appointed William (Bill) D. Humphries as CEO of Merz Inc., effective March 15. Merz Pharmaceuticals, LLC will continue to sell Xeomin for therapeutic uses in the US, following the ruling by Judge Andrew J. Guilford last Friday […]
‘Brotox’ trending as men become less afraid to look good
They call it “Brotox” — slang for Botox treatments for guys. Evan Lo Balbo had never heard of the word until his girlfriend suggested they do something to fight the mean signs of aging on their faces. But there he was, a manly man, sitting in a reclining chair, Dr. Richard Castellano pushing needles into […]
IAPAM Announces April Symposium Dates – April 28-29, 2012
Since 2006, over 1,000 physicians (MDs, DOs, NPs and PAs), as well as their staff have attended the IAPAM’s 2-day Aesthetic Medicine Symposiums and Friday hCG Physician Training sessions. Today, the IAPAM announces the dates for its April Symposium with Botox ® training, April 28-29, 2012. The number of patients turning to minimally invasive procedures […]
Botox – a potential for therapy of weak bladders in women
Botox could help people with weak bladders – a common condition called urinary incontinence. The study, published in the journal European Urology, was carried out at eight uro-gynecology centers in the UK from 2006 to 2009 by researchers from the University of Leicester. A total of 240 women were split into two groups, with 122 […]
Top-rated diets offer benefits for everyone
US News report assesses the efficacy of various well-known plans. Rating diets never gets old. That’s because dieting never gets old. It’s no wonder then, that for the second year in a row, US News created a buzz with its recent listing of the top diets of 2012. The rankings include 25 diets and are […]
42 Percent of Patients Receive Most of Their Information About Plastic Surgery from Social Media
New survey results released by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) showed more patients sought out social networking sites, rather than friends, for advice and information on facial plastic surgery before choosing a procedure in 2011. Academy surgeons found 42 percent of patients receive most of their information about plastic surgery […]
IAPAM Reports on Increase in Laser Training Consistent with Increase in Laser Treatments
In the upcoming year, successful aesthetic practices will offer “combination” treatment packages, integrating: facial injectables, medical skin care, IPL/laser rejuvenation and non-invasive body contouring. To develop these packages, physicians will require expert and physician lead training in lasers and light devices, botox ® and other cosmetic injectables, medical microdermabrasion and medical grade chemical peel, like […]
Move over Botox now there’s Xeomin, a new type of wrinkle treatment
Move over Botox, there’s a new kid on the block. It’s a new type of wrinkle treatment that may save you big bucks. Only a few doctors in the country are using it, and one of them is in South Florida. The product is called ‘Xeomin’. It’s been popular in Europe for years and […]
2011 Statistics Confirm that Botox ® Training Helps Physicians Capture Industry’s 5% Growth
The IAPAM offers physicians aesthetic training, the leading botox ® training, hCG training, and associated aesthetic medicine education (including training on lasers for skin rejuvenation and hair removal, medical microdermabrasion and medical grade chemical peels). The IAPAM’s Aesthetic Medicine Symposium offers the most comprehensive medical spa training, including: hands on, live demonstration and didactic instruction […]
NICE unconvinced by Botox for migraine
Healthcare cost-effectiveness body NICE is not convinced that Allergan’s anti-wrinkle injection Botox is worth using to treat migraines.Botox is licensed to prevent headaches in adults with chronic migraine, but the National Institute for Health and Clinical Excellence (NICE) said on Thursday the company had not provided sufficient evidence to prove its value.